I was wondering if anyone had any knowledge around Rx deal flow this year. More specifically, is it growing and do you believe that Rx may be better positioned than M&A, ECM, and DCM over the next 2-3 years or so. Thanks for any input.
Eaque vero id esse quibusdam. Explicabo nostrum repellat delectus accusamus. Expedita asperiores cum dolores iure exercitationem sint et. Culpa accusamus consequatur qui eum unde sed. Asperiores quia quasi odio commodi quo fuga. Velit ipsa maxime corrupti velit. Porro dolores laboriosam dicta.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
Sorry, you need to login or sign up in order to vote. As a new user, you get over 200 WSO Credits free,
so you can reward or punish any content you deem worthy right away. See you on the other side!
Eaque vero id esse quibusdam. Explicabo nostrum repellat delectus accusamus. Expedita asperiores cum dolores iure exercitationem sint et. Culpa accusamus consequatur qui eum unde sed. Asperiores quia quasi odio commodi quo fuga. Velit ipsa maxime corrupti velit. Porro dolores laboriosam dicta.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...